Gloster Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 1:36 am

Competitors of Gloster Ltd

All Competitor Stocks of Gloster Ltd

Quarterly Result

Last Updated: August 19, 2025, 2:35 pm

Below is a detailed analysis of the quarterly data for Gloster Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 305.63 Cr.. The value appears strong and on an upward trend. It has increased from 278.34 Cr. (Mar 2025) to 305.63 Cr., marking an increase of 27.29 Cr..
• For Expenses, as of Jun 2025, the value is 275.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 263.91 Cr. (Mar 2025) to 275.59 Cr., marking an increase of 11.68 Cr..
• For Operating Profit, as of Jun 2025, the value is 30.04 Cr.. The value appears strong and on an upward trend. It has increased from 14.43 Cr. (Mar 2025) to 30.04 Cr., marking an increase of 15.61 Cr..
• For OPM %, as of Jun 2025, the value is 9.83%. The value appears strong and on an upward trend. It has increased from 5.18% (Mar 2025) to 9.83%, marking an increase of 4.65%.
• For Other Income, as of Jun 2025, the value is 5.32 Cr.. The value appears to be declining and may need further review. It has decreased from 10.34 Cr. (Mar 2025) to 5.32 Cr., marking a decrease of 5.02 Cr..
• For Interest, as of Jun 2025, the value is 15.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.52 Cr. (Mar 2025) to 15.84 Cr., marking an increase of 5.32 Cr..
• For Depreciation, as of Jun 2025, the value is 14.25 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.41 Cr. (Mar 2025) to 14.25 Cr., marking an increase of 1.84 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.27 Cr.. The value appears strong and on an upward trend. It has increased from 1.84 Cr. (Mar 2025) to 5.27 Cr., marking an increase of 3.43 Cr..
• For Tax %, as of Jun 2025, the value is 43.07%. The value appears to be improving (decreasing) as expected. It has decreased from 226.09% (Mar 2025) to 43.07%, marking a decrease of 183.02%.
• For Net Profit, as of Jun 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from -2.32 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 5.32 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.74. The value appears strong and on an upward trend. It has increased from -2.12 (Mar 2025) to 2.74, marking an increase of 4.86.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 1:02 pm

Growth

Last Updated: September 5, 2025, 3:36 pm

Balance Sheet

Last Updated: July 25, 2025, 1:12 pm

Below is a detailed analysis of the balance sheet data for Gloster Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,072.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,099.00 Cr. (Mar 2024) to 1,072.00 Cr., marking a decrease of 27.00 Cr..
• For Borrowings, as of Mar 2025, the value is 579.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 194.00 Cr. (Mar 2024) to 579.00 Cr., marking an increase of 385.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 355.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 166.00 Cr. (Mar 2024) to 355.00 Cr., marking an increase of 189.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,018.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,470.00 Cr. (Mar 2024) to 2,018.00 Cr., marking an increase of 548.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,115.00 Cr.. The value appears strong and on an upward trend. It has increased from 893.00 Cr. (Mar 2024) to 1,115.00 Cr., marking an increase of 222.00 Cr..
• For CWIP, as of Mar 2025, the value is 85.00 Cr.. The value appears to be declining and may need further review. It has decreased from 118.00 Cr. (Mar 2024) to 85.00 Cr., marking a decrease of 33.00 Cr..
• For Investments, as of Mar 2025, the value is 113.00 Cr.. The value appears to be declining and may need further review. It has decreased from 142.00 Cr. (Mar 2024) to 113.00 Cr., marking a decrease of 29.00 Cr..
• For Other Assets, as of Mar 2025, the value is 705.00 Cr.. The value appears strong and on an upward trend. It has increased from 317.00 Cr. (Mar 2024) to 705.00 Cr., marking an increase of 388.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,018.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,470.00 Cr. (Mar 2024) to 2,018.00 Cr., marking an increase of 548.00 Cr..

Notably, the Reserves (1,072.00 Cr.) exceed the Borrowings (579.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Gloster Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -12.20. This value is below the healthy minimum of 5. It has decreased from 22.25 (Mar 24) to -12.20, marking a decrease of 34.45.
• For Diluted EPS (Rs.), as of Mar 25, the value is -12.20. This value is below the healthy minimum of 5. It has decreased from 22.25 (Mar 24) to -12.20, marking a decrease of 34.45.
• For Cash EPS (Rs.), as of Mar 25, the value is 33.27. This value is within the healthy range. It has decreased from 57.29 (Mar 24) to 33.27, marking a decrease of 24.02.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 990.05. It has decreased from 1,014.47 (Mar 24) to 990.05, marking a decrease of 24.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 990.05. It has decreased from 1,014.47 (Mar 24) to 990.05, marking a decrease of 24.42.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 671.45. It has increased from 590.68 (Mar 24) to 671.45, marking an increase of 80.77.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 66.38. This value is within the healthy range. It has decreased from 71.91 (Mar 24) to 66.38, marking a decrease of 5.53.
• For PBIT / Share (Rs.), as of Mar 25, the value is 20.92. This value is within the healthy range. It has decreased from 36.87 (Mar 24) to 20.92, marking a decrease of 15.95.
• For PBT / Share (Rs.), as of Mar 25, the value is -1.11. This value is below the healthy minimum of 0. It has decreased from 34.55 (Mar 24) to -1.11, marking a decrease of 35.66.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -12.20. This value is below the healthy minimum of 2. It has decreased from 22.25 (Mar 24) to -12.20, marking a decrease of 34.45.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.20. This value is below the healthy minimum of 2. It has decreased from 22.25 (Mar 24) to -12.20, marking a decrease of 34.45.
• For PBDIT Margin (%), as of Mar 25, the value is 9.88. This value is below the healthy minimum of 10. It has decreased from 12.17 (Mar 24) to 9.88, marking a decrease of 2.29.
• For PBIT Margin (%), as of Mar 25, the value is 3.11. This value is below the healthy minimum of 10. It has decreased from 6.24 (Mar 24) to 3.11, marking a decrease of 3.13.
• For PBT Margin (%), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 10. It has decreased from 5.84 (Mar 24) to -0.16, marking a decrease of 6.00.
• For Net Profit Margin (%), as of Mar 25, the value is -1.81. This value is below the healthy minimum of 5. It has decreased from 3.76 (Mar 24) to -1.81, marking a decrease of 5.57.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.81. This value is below the healthy minimum of 8. It has decreased from 3.76 (Mar 24) to -1.81, marking a decrease of 5.57.
• For Return on Networth / Equity (%), as of Mar 25, the value is -1.23. This value is below the healthy minimum of 15. It has decreased from 2.19 (Mar 24) to -1.23, marking a decrease of 3.42.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 10. It has decreased from 3.04 (Mar 24) to 1.44, marking a decrease of 1.60.
• For Return On Assets (%), as of Mar 25, the value is -0.66. This value is below the healthy minimum of 5. It has decreased from 1.65 (Mar 24) to -0.66, marking a decrease of 2.31.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.10 (Mar 24) to 0.32, marking an increase of 0.22.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.52. This value is within the healthy range. It has increased from 0.16 (Mar 24) to 0.52, marking an increase of 0.36.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. It has decreased from 0.46 (Mar 24) to 0.42, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.54. This value is within the healthy range. It has decreased from 2.04 (Mar 24) to 1.54, marking a decrease of 0.50.
• For Quick Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.83, marking a decrease of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 4. It has decreased from 2.14 (Mar 24) to 1.77, marking a decrease of 0.37.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 89.87 (Mar 24) to 0.00, marking a decrease of 89.87.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 34.90 (Mar 24) to 0.00, marking a decrease of 34.90.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 10.13 (Mar 24) to 0.00, marking a decrease of 10.13.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 65.10 (Mar 24) to 0.00, marking a decrease of 65.10.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.01. This value is within the healthy range. It has decreased from 31.05 (Mar 24) to 3.01, marking a decrease of 28.04.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 3. It has decreased from 10.61 (Mar 24) to 0.44, marking a decrease of 10.17.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,165.92. It has increased from 1,046.99 (Mar 24) to 1,165.92, marking an increase of 118.93.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 1.62 (Mar 24) to 1.59, marking a decrease of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 16.05. This value exceeds the healthy maximum of 15. It has increased from 13.30 (Mar 24) to 16.05, marking an increase of 2.75.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.39 (Mar 24) to 0.84, marking a decrease of 0.55.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 10.12 (Mar 24) to 0.00, marking a decrease of 10.12.
• For Price / BV (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.57, marking a decrease of 0.23.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.39 (Mar 24) to 0.84, marking a decrease of 0.55.
• For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to -0.02, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness